Skip to main content
Sartorius Stedim Biotech logo

Sartorius Stedim Biotech — Investor Relations & Filings

Ticker · DIM ISIN · FR0013154002 LEI · 52990006IVXY7GCSSR39 PA Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2025-01-06 Declaration of Voting R…
Country FR France
Listing PA DIM

About Sartorius Stedim Biotech

https://www.sartorius.com/en

Sartorius Stedim Biotech is a leading international provider of equipment and services for the biopharmaceutical industry. The company offers integrated solutions that support the entire lifecycle of drug development and manufacturing, from research and development to quality assurance and commercial production. Its comprehensive portfolio includes technologies for filtration, fluid management, fermentation, cell culture, and purification. Key products encompass bioreactors, single-use systems, process filtration equipment, cell culture media, and data analytics software. Sartorius Stedim Biotech enables its customers to develop and manufacture biotech medications, including cell and gene therapies, more efficiently and safely, helping to accelerate the translation of scientific discoveries into patient care.

Recent filings

Filing Released Lang Actions
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states its purpose in the title: 'DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL'. It provides a table detailing the total number of shares, theoretical voting rights, and net voting rights as of a specific date (December 31, 2024), referencing French commercial code (Article L 233-8-II) and AMF regulations. This content directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official announcements related to voting rights structure.
2025-01-06 English
Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'DECLARATION RELATIVE AU NOMBRE D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL' (Declaration relative to the number of shares and voting rights comprising the share capital) and references French regulatory articles (Code de commerce and AMF general regulation). It provides a table detailing the total number of shares, theoretical voting rights, and net voting rights as of a specific date (31 Décembre 2024). This type of mandatory disclosure regarding the capital structure and voting power aligns most closely with regulatory reporting concerning share capital changes or ownership structure. While it is a specific regulatory filing, none of the provided codes perfectly match a 'Share Capital Declaration'. However, it is a formal regulatory disclosure. Given the options, it is a specific regulatory announcement. It is not an AGM, 10-K, ER, or IR. It is not a Director's Dealing (DIRS) or Major Shareholding (MRQ). It is a formal declaration about the capital structure. Since 'Share Issue/Capital Change' (SHA) relates to changes in capital, and this document reports the current state of capital and voting rights, SHA is the closest fit among the specific options, as it pertains directly to the capital structure. If SHA is interpreted strictly as an announcement of a *change* (issue/split), and this is just a periodic report, then 'Regulatory Filings' (RNS) would be the fallback. Given the content is a formal declaration about the composition of the capital, SHA is the most relevant specific category.
2025-01-06 French
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states its purpose in the header: 'DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL'. It provides a table detailing the total number of shares, theoretical voting rights, and net voting rights as of a specific date (November 30, 2024), referencing French commercial code and AMF regulations. This content directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes and voting rights disclosures.
2024-12-03 English
Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'DECLARATION RELATIVE AU NOMBRE D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL' (Declaration relative to the number of shares and voting rights comprising the share capital) and cites French commercial code (Article L 233-8-II) and AMF regulations. It provides a table detailing the total number of shares and theoretical/net voting rights as of a specific date (30 Novembre 2024). This type of mandatory disclosure regarding the total share capital and voting power structure is a specific regulatory filing requirement, often related to capital structure changes or periodic updates on ownership structure. It does not fit the definitions for Annual Report (10-K), Earnings Release (ER), Interim Report (IR), or a general announcement of a report (RPA). It most closely aligns with a specific regulatory disclosure concerning capital structure, which falls under the general 'Regulatory Filings' (RNS) category, as there is no specific code for 'Share Capital Declaration'. Given the nature of the data (share count and voting rights), it is a mandatory regulatory disclosure.
2024-12-03 French
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL' and explicitly references French commercial code (Article L 233-8-II) and AMF regulations. It provides a table detailing the total number of shares and the corresponding theoretical and net voting rights as of a specific date (October 31, 2024). This content directly relates to the official disclosure of voting rights and capital structure, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category (DVA), as it is a formal declaration regarding voting rights, even if it's not the result of a specific vote, but rather the current state of voting rights.
2024-11-04 English
Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'DECLARATION RELATIVE AU NOMBRE D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL' (Declaration relative to the number of shares and voting rights comprising the share capital) and cites French regulatory articles (Article L 233-8-II du Code de commerce and article 223-6 du règlement général de l'AMF). It provides a table detailing the total number of shares and the total theoretical and net voting rights as of a specific date (31 Octobre 2024). This content specifically relates to the official disclosure of the total voting rights and share capital structure, which is a mandatory regulatory filing requirement in many jurisdictions, often related to capital structure changes or periodic updates. Among the provided codes, 'SHA' (Share Issue/Capital Change) is the most appropriate fit as it deals directly with the composition of the share capital and voting rights, which underpins capital structure disclosures. While 'RNS' is a fallback, 'SHA' is more specific to capital structure reporting.
2024-11-04 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.